HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhengwei Cai Selected Research

phenyl-N-tert-butylnitrone

11/2009Interleukin-1beta-induced brain injury in the neonatal rat can be ameliorated by alpha-phenyl-n-tert-butyl-nitrone.
12/2008alpha-Phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced brain injury and improves neurological reflexes and early sensorimotor behavioral performance in juvenile rats.
3/2008Alpha-phenyl-n-tert-butyl-nitrone ameliorates hippocampal injury and improves learning and memory in juvenile rats following neonatal exposure to lipopolysaccharide.
2/2008alpha-Phenyl-n-tert-butyl-nitrone reduces lipopolysaccharide-induced white matter injury in the neonatal rat brain.
9/2006Neuroprotection of alpha-phenyl-n-tert-butyl-nitrone on the neonatal white matter is associated with anti-inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhengwei Cai Research Topics

Disease

13Brain Injuries (Brain Injury)
11/2009 - 02/2002
8Inflammation (Inflammations)
06/2022 - 06/2003
5Hypoxia (Hypoxemia)
02/2016 - 02/2002
5Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
04/2011 - 02/2002
4Ischemia
02/2016 - 02/2002
4Encephalitis (Encephalitis, Rasmussen)
04/2013 - 06/2010
4Body Weight (Weight, Body)
01/2013 - 10/2004
4Infections
11/2009 - 10/2004
3Wounds and Injuries (Trauma)
12/2021 - 06/2003
2Osteoarthritis
10/2022 - 02/2022
2Neoplasms (Cancer)
01/2018 - 11/2017
2Neurodegenerative Diseases (Neurodegenerative Disease)
06/2013 - 01/2013
2Periventricular Leukomalacia (Neonatal Cerebral Leukomalacia)
08/2007 - 04/2005
2Necrosis
10/2004 - 09/2004
2Gliosis
09/2004 - 06/2003
1Intervertebral Disc Degeneration
06/2022
1Cytokine Release Syndrome
01/2022
1Pneumonia (Pneumonitis)
01/2022
1COVID-19
01/2022
1Thrombosis (Thrombus)
01/2022
1Hearing Loss (Hearing Impairment)
01/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Colitis
01/2021
1Rhinosinusitis
10/2020
1Spinal Cord Injuries (Spinal Cord Injury)
01/2019
1Hepatocellular Carcinoma (Hepatoma)
01/2018
1Glioma (Gliomas)
01/2018
1Neuroinflammatory Diseases
02/2016
1Autism Spectrum Disorder
05/2015
1Parkinson Disease (Parkinson's Disease)
01/2013
1Demyelinating Diseases (Demyelinating Disease)
01/2012
1Autistic Disorder (Autism)
11/2011
1Substance-Related Disorders (Drug Abuse)
10/2011
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2011
1Hypothermia
04/2011
1Pain (Aches)
01/2011
1Hyperalgesia
01/2011
1Cerebral Hemorrhage
06/2010
1Neurologic Manifestations (Neurological Manifestations)
10/2005
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
06/2005
1Reperfusion Injury
08/2003

Drug/Important Bio-Agent (IBA)

11LipopolysaccharidesIBA
01/2022 - 02/2003
10CytokinesIBA
01/2021 - 02/2003
8HydrogelsIBA
10/2022 - 01/2019
5phenyl-N-tert-butylnitroneIBA
11/2009 - 09/2006
4Insulin-Like Growth Factor I (IGF-1)IBA
04/2011 - 11/2005
4Oxygen (Dioxygen)IBA
04/2011 - 02/2002
4Interleukin-1beta (Interleukin 1 beta)IBA
01/2011 - 06/2003
3Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2011 - 02/2003
3Myelin Basic ProteinIBA
06/2010 - 06/2003
2Pharmaceutical PreparationsIBA
10/2022 - 05/2012
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2018
2Serotonin (5 Hydroxytryptamine)IBA
05/2015 - 11/2011
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
05/2015 - 11/2011
2Insulin (Novolin)FDA Link
06/2009 - 11/2005
2Free RadicalsIBA
09/2006 - 05/2004
2Minocycline (Cyclops)FDA LinkGeneric
07/2006 - 10/2005
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2004 - 06/2003
1LubricantsIBA
10/2022
1GelsIBA
10/2022
1Therapeutic UsesIBA
06/2022
1Lactic Acid (Lactate)FDA LinkGeneric
06/2022
1Heparin (Liquaemin)FDA LinkGeneric
01/2022
1SilverIBA
01/2022
1Bovine Serum AlbuminIBA
01/2022
1LigandsIBA
01/2022
1MetalsIBA
01/2022
1CollagenIBA
12/2021
1ChemokinesIBA
12/2021
1Sulfhydryl Compounds (Thiols)IBA
12/2021
1Anti-Bacterial Agents (Antibiotics)IBA
10/2020
1Biological ProductsIBA
01/2019
1CateninsIBA
01/2018
1CurcuminIBA
11/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2016
1ErythropoietinFDA Link
02/2016
1SynucleinsIBA
06/2013
1Celecoxib (Celebrex)FDA Link
04/2013
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
04/2013
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2013
1PesticidesIBA
01/2013
1RotenoneIBA
01/2013
1Indicators and Reagents (Reagents)IBA
10/2011
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
05/2011
1Free Radical ScavengersIBA
12/2008
1AntioxidantsIBA
12/2008
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
11/2005
1Bromodeoxyuridine (BrdU)IBA
11/2005
12',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA
06/2005
1Caspase 3 (Caspase-3)IBA
06/2005
1Hematoxylin (Haematoxylon)IBA
10/2004
1Eosine Yellowish-(YS) (Eosin)IBA
10/2004
1Interleukin-10 (Interleukin 10)IBA
10/2004
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2003
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2003

Therapy/Procedure

5Injections
06/2022 - 10/2020
5Microspheres (Microsphere)
06/2022 - 01/2021
3Ligation
04/2011 - 02/2002
2Therapeutics
10/2020 - 10/2004
1Intranasal Administration
06/2009